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Abstract
Objective: To investigate whether Danish providers of general health checks present a balanced account of possible
benefits and harms on their websites and whether the health checks are evidence-based.
Methods and Design: Cross-sectional study. The search engines Google and Jubii (Danish) were in July and August 2009
used to identify 56 websites using Danish search terms for ‘‘health check’’ and ‘‘health examination’’. The content of the
websites were evaluated using a checklist with 15 officially recommended information items. All tests offered through the
websites were registered. The evidence for tests offered through at least 10% of the websites was identified in structured
searches using PubMed and The Cochrane Library.
Results: We found 36 different tests on 56 websites offering health checks. Twenty one tests were offered on at least 10% of
the websites. Seventeen (81%) of these tests were unsupported by evidence, or there was evidence against them for
screening purposes. We found evidence supporting screening using body-mass-index, blood pressure, cholesterol, and
faecal occult blood testing. None of the websites mentioned possible risks or harms. The websites presented a median of 1
of the 15 information items; the highest number from any provider was 2.
Conclusions: Information from Danish providers of health checks was sparse and tests were often offered against existing
evidence or despite lack of evidence. None of the included websites mentioned potential risks or harms.
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Introduction
Regular health checks of healthy individuals are intended to
identify risk factors and early signs of disease, preventing future
illness through early intervention. This strategy may seem
immediately appealing but in some cases, potential harms can
outweigh the potential benefits.
Quite often, healthy people with common risk factors would not
have developed the disease intended to prevent, even without
screening. In these cases, the identification of risk factors
represents overdiagnosis, which may lead to unnecessary addi-
tional diagnostic workups with possible complications. It may also
increase the use of medication, which will usually only be harmful
in overdiagnosed people. Identification of risk factors may also
cause psychological stress, with a negative impact on quality of life.
Health checks are an unregulated market, which adds to the
complexity. Private practices are not obliged to provide further
diagnostic workups, treatment, or follow-up tests when they
uncover risk factors. The expenses associated with this can drain
resources from public health care that could perhaps be used for a
better purpose. It is a common misconception that screening
programmes and early treatment will generally save money in the
long run, and some screening programmes are very costly [1].
Some trials of health checks have found beneficial effects on risk
factors for cardiovascular disease [2] [3] [4], but trials with
morbidity and mortality as outcomes have not been convincing.
An American randomized trial published in 1986 evaluated
annual health checks through 16 years and included 10,713 men
and women aged 35–54 years. It found an effect on mortality
related to pre-specified potentially postponable causes, but did not
find any difference in overall mortality or hospitalization rate. A
British trial from 1977 evaluated two general health checks of
7,229 men and women aged 40–64 years and reached similar
results after 9 years of follow-up. A Swedish trial from 1998
randomized 3,064 men and women to a single general health
check and 29,122 to a control group and did not find an effect on
mortality after 22 years of follow-up. The health checks provided
in these trials were all rather extensive (table 1).
The health check industry is growing fast in many countries. In
Denmark, this is partly because new legislation provided tax-
exemption for private health insurance. We studied the websites
from Danish providers of general health checks and quantified the
tests and the information offered. We also did literature searches to
see if the included tests were supported by evidence.
Materials and Methods
We included websites that advertised screening for several
diseases and risk factors as a package. Websites offering screening
for single specific diseases or non-scientific tests (e.g. iris analysis)
were excluded.
In Denmark, 60% of the population use the Internet to gather
information on health issues [5]. We therefore used simple
searches to locate providers of health checks that potential
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Google and the Danish search engine Jubii, using Danish terms
for health checks (Sundhedstjek, Sundhedscheck, Sundhedsun-
dersøgelse, Helbredstjek, Helbredscheck and Helbredsundersø-
gelse). CGL browsed the first 10 pages of results retrieved for
each search term, 120 pages in total. These were saved as PDF
documents. When a search term is entered into the Google
search bar, targeted advertising of websites appears in the top
and the right hand side of the page. These websites were also
included.
We used a pre-specified checklist of 15 information items to
study whether the information presented on websites by
providers of health checks gave a balanced account of the
possible benefits and harms of the tests offered (table 2). These
15 items are recommended information items about screening
healthy people from the World Health Organization and The
Danish National Board of Health [6]. Overall, they address
which diseases are being screened for, the possibility of a false
positive or false negative result, the accuracy of the test to
diagnose a person as being ill or healthy, and information on the
number of people being overdiagnosed and overtreated. In
addition, the websites were searched for information on how the
test answers would be communicated and how a possible illness
was to be treated.
Finally, CGL reviewed the literature for evidence about the
individual tests, restricted to those that were represented on more
than 10% of the websites. The Cochrane Library and PubMed
were searched for a specific illness, condition or test, e.g.
‘‘hypertension’’ (condition) or ‘‘blood pressure’’ (test), combining
this with either ‘‘asymptomatic’’ or ‘‘screening.’’ All reviews and
guidelines identified by the searches, and relevant studies
indentified in the reference lists, were retrieved.
Results
We identified 56 websites from providers of health checks; 53
were commercial organizations (20 run by doctors and 33 run by
other medical personnel) and 3 from non-profit organizations (The
Danish Heart Organization, Hørsholm Municipality and Hjørring
Municipality).
The websites offered 36 different screening tests, and 21 of these
were represented on more than 10% of the websites (Table 3). Of
these 21 tests, we found recommendations against using the test for
screening purposes for 48% (n=10) of the tests and lacking or
inconclusive evidence for another 33% (n=7) of the tests, in total
81% (n=17).
The sites included a median of 1 information item out of the 15
recommended items; the highest number included was 2. The
most common information item (70% of the sites, n=56) was how
the test result was provided (a written report, personal meeting, or
both).
None of the websites quantified the expected benefit of
screening or mentioned the harms. Further, there was no
information on the risk of false negative results, the risk of false
positive results, the level of overdiagnosis, the level of overtreat-
ment, the lifetime risk for developing the disease tested for, the
sensitivity, the specificity, the negative predictive value, the positive
predictive value, or the psychological stress related to false positive
results (table 2).
Evidence existed to support screening asymptomatic people for
body-mass-index [7,8], blood pressure [9], cholesterol [7], and
faecal occult blood tests [10].
There was inconclusive evidence on screening for thyroid-
stimulating hormone (TSH) and it was unclear whether treatment
will improve the quality of life in otherwise healthy asymptomatic
adults with abnormal TSH levels [11]. No studies have
demonstrated hearing screening to improve hearing function.
We found a recommendation for screening older people but a
specific age cut-off is unclear [7] and a randomised controlled trial
found no affect of screening for hearing loss [12]. Vision screening
in adults older than 65 years of age is recommended [7] but direct
evidence shows no benefit and the U.S. Preventive Tasks Force
conclude that more research is needed [13]. For these reasons we
found the evidence inconclusive for vision and hearing screening
in adults.
No studies or recommendations were found addressing the
benefits and harms of screening asymptomatic people for alanine
aminotransferase (ALAT), aspartate aminotransferase (ASAT),
infection parameters (C-reactive protein, sedimentation rate or
white blood cells), fitness ratings or fat percentages.
Evidence, recommendations, or both, were found against
offering a general physical examination [7], screening for prostate
cancer with prostate specific antigen-testing [14] [15], anaemia
blood tests [7], coronary heart disease with electrocardiograms or
Table 1. Content of health checks in randomised trials.
Friedman et al. [2] The South-East London Screening Study Group. [3] Theobald et al. [4]
A medical questionnaire, blood pressure, electrocardiogram,
audiography, visual test, tonometry, spirometry, chest X-ray,
mammography for women age 48 years and older, urine
analysis, blood tests incl. haematology, serum chemistry
panels, gynecological examination, Papanicolaou cervical
smear, sigmoidoscopy for persons over 40 years, and a
follow-up visit to a physician for test results.
A self-administered symptoms questionnaire, interviewer-
administered questions, body proportions, weight and
height, visual test, audiometry, chest X-ray, lung function
tests, electrocardiogram, blood pressure, blood tests
(Haemoglobin, packed cell volume, blood urea, random
blood sugar, protein-bound iodine, cholesterol, uric acid),
stool for occult blood and basic physician examination.
A postal questionnaire, blood
tests, electrocardiogram, exercise
tests, psychological tests and eye
and dental examinations.
doi:10.1371/journal.pone.0033694.t001
Table 2. Information items on websites.
Websites (n=56)
Information
Absolute
number Pct (%)
Presentation of test answers (personal meeting,
written report, or both)
39 70
Diseases screened for 6 11
Other relevant information on test or results 3 5
No websites quantified the effect of screening, or mentioned the risk of false
negative results, false positive results, overdiagnosis, overtreatment, lifetime
risk for developing the disease tested for, sensitivity, specificity, negative
predictive value, positive predictive value, or the psychological stress related to
false positive results and or treatment of early disease.
doi:10.1371/journal.pone.0033694.t002
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[7,17,18], kidney disease with serum creatinine [19], urinary
dipstick [7,20,21], ‘lab tests’ [7], and spirometry [22] for
asymptomatic persons. The results of our review of the evidence
are summed up in Table 4.
Discussion
The information on Danish websites from providers of health
checks was sparse and severely biased in favour of health checks.
None of the websites quantified the expected benefit of screening
or provided information on possible risks and harms. The majority
of the tests offered (81%) were either recommended against, or
there was a lack of evidence or recommendations.
Health checks may be of value to individuals seeking
reassurance on their state of health but suppliers must provide
information that no screening test is perfect and may result in
important harms. A negative result is no guarantee that a person is
healthy, or that they will stay healthy. Potential participants must
be also be informed that most tests were often developed for
diagnostic purposes, not for screening, and that this would be
expected to decrease their reliability substantially. Potential
participants must also be informed that the results of the tests
are often evaluated by a nurse or other staff who are not trained to
diagnose an illness or prescribe treatment. This information was
not presented on any website that advertised health checks by
nurses or other healthcare personnel.
For all screening tests, the low prevalence of disease in a healthy
population and a different spectrum of disease severity among
those who actually have the disease, will cause a reduction in the
predictive value of a positive test result. This reduction increases
the risk that healthy individuals will receive a false-positive result
Table 3. Tests provided as part of general health checks in
Denmark.
Websites n=56
Screening name or type Absolute Pct
Cancer tests
Blood in faeces 8 14
PSA 7 13
Meeting with health professionel
Clinical examination by doctor 13 23
Conversation or questionnaires 26 46
Vision and hearing 7 13
Heart and lung measures
Blood pressure 46 82
Electrocardiogram/ECG (rest) 13 23
Electrocardiogram/ECGE (exercise) 16 29
Lung function test/spirometry 18 32
Radiology
X-ray thorax 5 9
Urinary dipstick 13 23
Lab tests
Blood sugar 47 84
Kidney tests 12 21
Lipids (Cholesterol) 49 88
Liver tests (ALAT or ASAT) 10 18
Infection parameters (CRP, Sedimentation
rate or white blood cells)
61 1
Electrolytes 5 9
Clinical biochemistry tests referred to
as ‘‘Blood/Lab’’ tests (not specified)
10 18
Haemoglobin/Blood pct 12 21
Thyroidea (TSH) 6 11
Lung tests (PO2 or CO in blood) 5 9
Body measures
Body composition (e.g. fat percentage) 35 63
Weight, height, waist (e.g. Body mass index) 43 77
Fitness test/rating 24 43
Unknown tests
Strength and suppleness 4 7
Unknown fitness tests (e.g. physical age or oxidative stress) 8 14
The following tests were represented on less than 3 web sites: Rectoscopy,
Vaginal smear, Heart blood tests (Pro-BNP), Echocardiogram, Pancreas (alfa
amylase), Mammography, Ultrasound of abdomen, Unspecified/Unknown (eg.
Bone marrow test), Virus parameters (HIV, Hepatitis B/C) and Vitamins (25-OH-
D-Vit.)
doi:10.1371/journal.pone.0033694.t003
Table 4. Overview of screening tests.
Screening test
Health checks
offering test
n=56 Recommendation
Cholesterol 88% Men.age 34
Women .age 44 [7]
Blood glucose 84% Recommendation against screening [7]
[17] [18]
Blood pressure 82% Screening recommended [9]
Body mass index 77% Screening recommended [7] [8]
Body composition
(fat percentage)
63% No studies or recommendations found
Fitness rating 43% No studies or recommendations found
Lung function test 32% Recommendation against screening [22]
ECG 29% Recommendation against screening [7]
[16]
ECGE 23% Recommendation against screening [7]
[16]
Physical examination 23% Recommendation against screening [7]
Urinary dipstick 23% Recommendation against screening [7]
[20] [21]
Haemoglobin 21% Recommendation against screening [7]
Kidney test 21% Recommendation against screening [19]
ALAT/ASAT 18% No studies or recommendations found
Unspecified
‘‘blood/lab’’ testing
18% Recommendation against screening [7]
Faecal occult test 14% Screening recommended [10]
PSA 13% Recommendation against screening
[14] [15]
Hearing 13% Inconclusive evidence [12]
Recommendation for ‘‘older adults’’ [7]
Vision 13% Inconclusive evidence [13]
Recommendation for adults.age 65 [7]
Infection parameters 11% No studies or recommendations found
TSH 11% Inconclusive evidence [11]
doi:10.1371/journal.pone.0033694.t004
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economic consequences of screening tests with a large proportion
of false-positives may therefore be considerable. These costs are
covered by the public healthcare system, which may lead to a
suboptimal allocation of resources.
An additional problem is that pre-symptomatic treatment might
not improve the long-term mortality or morbidity compared to
symptomatic treatment, but can have additional side effects and
will also lead to more years being a patient rather than staying
healthy.
Information on websites from providers of general health checks
was sparse, the expected benefit of screening was not quantified,
and the risks and harms of the screening tests were not described
on any website. Eighty-one percent of the tests included in the
health checks were either recommended against for screening
purposes, or there were lacking evidence or recommendations for
their use as screening tools.
We believe it is unethical to advertise health checks that lack
evidence to support them and indefensible to promote screening
tests when there is evidence against using the tests for screening
purposes. It is also counter to Danish health legislation to provide
information about health interventions without presenting a
balanced account of the benefits and harms, even if the harms
are rare.
We call for better regulation of this growing industry.
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